Last reviewed · How we verify

NCT06361485

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

Recruiting now Phase 1 Last updated 11 April 2024
What this trial tests

Phase 1 trial testing Lumbar Injections with 10cc's of Wharton's Jelly Allograft in Low Back Pain in 100 participants. Currently enrolling.

Timeline
25 March 2024
Primary endpoint
31 March 2027
1 April 2028

Quick facts

Lead sponsorR3 Stem Cell
PhasePhase 1
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment100
Start date25 March 2024
Primary completion31 March 2027
Estimated completion1 April 2028
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

R3 Stem Cell — full company profile →

Who can join

20 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Precision Medicine.
    Sharma A, Yadav A, Nandy A, Ghatak S. · · 2024 · cited 40× · PMID 38931833 · DOI 10.3390/pharmaceutics16060709
  2. Cell-based therapies for intervertebral disc degeneration: Navigating the path from promise to clinical reality
    Shi L, Jiang L, Xing T, Liu K, et al · · 2026

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other R3 Stem Cell trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06361485.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing